Supplier Type
- Trader
- contract manufacturer
- custom synthesis
- Reagent
- Manufacturer
Supplier Region
- Gujarat(35)
- Maharashtra(31)
- Tamil Nadu(3)
- New Delhi(5)
- Ahmedabad(17)
- Rajasthan(1)
- Andhra Pradesh(1)
- Delhi(12)
- Mumbai(44)
- Haryana(2)
- Uttar Pradesh(6)
- Pune(2)
- Vadodara(12)
- Hyderabad(23)
- Karnataka(11)
- Bangalore(1)
- Kerela(1)
- Beijing(2)
- Telangana(1)
- Kolkata(4)
- Nagpur(1)
- Punjab(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- Powder 99%
- NLT95%
- NLT 95%
- NLT 90%
- More than 98%
- more than 95%
- more than 90%
- MINIMUM 99%
- minimum 96%
- Min 98 %
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Empagliflozin intermediate, Dapagliflozin Impurity
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- Cytidine 5'-Monophosphate Disodium Salt (C9H14N3Na2O8P) - High-purity pharmaceutical-grade
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.99%
- 99.98%
- 99.95%
- 99.91%
- 99.9%
- 99.86%
- 99.85%
- 99.73%
- 99.55 % MINIMUM
- 99.5%
- 99.42%
- 99.29%
- 99.10%
- 99.0%
- 99%+
- 99% min
- > 99%
- 99%
- >99%
- 99 % MINIMUM
- 99 %
- 98=%
- 98+
- 98.60%
- >98.5%
- 98.5
- 98.12%
- 98% Min.
- 98% Min
- 98%
- >98%
- 98 % min
- 98
- 97-99%
- 97-99 %
- 97.57%
- > 97.5 %
- 97% min
- 97%
- >97%
- 97 %
- 96+1%
- 96.80%
- > 96.5 %
- 96.5 - 103.5 %
- 96.39%
- 96.14%
- 96% Minimum
- 96% - 104%
- 96%
- 96 %
- 95-98%
- 95.48%
- 95% - 98%
- >95%
- 95%
- 95 %
- 92-95%
- >92%
- 90%-95%
- 90% min
- 90%
- >90%
- 89%
- 85 percent Min
- 80% min
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100%
- 0.04%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 10g
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 25MG
- 1g
- 5g
- 25g
- 50g
- 100g
- 500g
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 95NLT %
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 103kg
- 124kg
- 127kg
- 136kg
- 137kg
- 250kg
- 500kg
- 1MT
-
Naproxen sodium
26159-34-2
-
Disodium hydrogen phosphate dihydrate
10028-24-7
-
6-Nitro-1,3-benzoxazole
30693-53-9
-
((3AS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone
1103738-19-7
-
4-Amino-benzenesulfonic acid monosodium salt
515-74-2
-
Sucrose octasulfate Potassium salt
73264-44-5
-
Dipotassium 7-hydroxynaphthalene-1,3-disulphonate
842-18-2
-
Sodium 2-chloro-5-nitrobenzenesulfonate
946-30-5
-
Cefuroxime sodium
56238-63-2
-
6-Hydroxy-2,4,5-triaminopyrimidine sulfate
39267-74-8
Naproxen sodium salt 26159-34-2
Naproxen sodium salt 26159-34-2
Phosphoric acid disodium salt dihydrate 10028-24-7
2-Amino-5-nitrobenzenesulfonic Acid Sodium Salt 30693-53-9
(5S)-D-xylo-Pentodialdo-5,2-furanose, 4,5-O-(1-Methylethylidene)-1-C-4-Morpholinyl 1103738-19-7
Sulfanic acid sodium salt 515-74-2
Sucrose Octasulfate Potassium Salt 73264-44-5
2-Naphthol-6,8-disulfonic acid dipotassium salt 842-18-2
4 Nitro Chloro Benzene 2 Sulphonic Acid,sodium salt 946-30-5
Cefuroxime sodium salt 56238-63-2